BALAXI PHARMACEUTICALS
Back to Cashflow Statement
|
BALAXI PHARMACEUTICALS Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹-35 Cr | ₹4.87 Cr | ₹6.08 Cr | ₹34 Cr | ₹0.00 Cr |
What is the latest Cash Flow from Operating Activities ratio of BALAXI PHARMACEUTICALS ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹-35 Cr |
| Mar2024 | ₹4.87 Cr |
| Mar2023 | ₹6.08 Cr |
| Mar2022 | ₹34 Cr |
| Mar2021 | ₹0.00 Cr |
How is Cash Flow from Operating Activities of BALAXI PHARMACEUTICALS Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-35 Cr | Negative | |
| Mar2024 | ₹4.87 Cr | -19.90 | |
| Mar2023 | ₹6.08 Cr | -82.21 | |
| Mar2022 | ₹34 Cr | 1,138,066.67 | |
| Mar2021 | ₹0.00 Cr | - | |
Compare Cash Flow from Operating Activities of peers of BALAXI PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BALAXI PHARMACEUTICALS | ₹86.5 Cr | -9.3% | -23.7% | -76.6% | Stock Analytics | |
| ADANI ENTERPRISES | ₹238,177.0 Cr | -4% | -21.2% | -20.7% | Stock Analytics | |
| REDINGTON | ₹15,842.7 Cr | -3% | -17.8% | -17.3% | Stock Analytics | |
| HONASA CONSUMER | ₹9,993.7 Cr | 6.1% | -2% | 27% | Stock Analytics | |
| MMTC | ₹8,280.0 Cr | -6.4% | -16.4% | -1.3% | Stock Analytics | |
| LLOYDS ENTERPRISES | ₹6,839.0 Cr | -2.1% | -23.6% | 5% | Stock Analytics | |
BALAXI PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BALAXI PHARMACEUTICALS | -9.3% |
-23.7% |
-76.6% |
| SENSEX | -3.5% |
-12.5% |
-6.5% |
You may also like the below Video Courses